Department of Anesthesiology and Pain Management, The University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Department of Anesthesiology and Pain Management, The University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
J Clin Anesth. 2021 Dec;75:110470. doi: 10.1016/j.jclinane.2021.110470. Epub 2021 Aug 5.
In the initial description of the serratus anterior plane block (SAPB), both superficial and deep SAPB provided effective blockade. The purpose of this study was to investigate the difference in opioid consumption and postoperative analgesia between superficial and deep SAPB for patients undergoing mastectomy.
Randomized prospective trial.
Academic hospital.
64 women, >18 years of age, ASA I-III, undergoing single or bilateral mastectomy, with and without lymph node biopsy, with and without tissue expander reconstruction.
Either superficial or deep SAPB by an ultrasound-guided technique in addition to multimodal analgesia.
The primary outcome was opioid consumption in the first 24 h. Secondary outcomes were pain scores, satisfaction scores, incidence of PONV, length of stay and block performance time.
Subjects who received a deep SAPB required 30% less oral morphine equivalents (OME) (113.5 mg vs. 147 mg, p = 0.009) and reported lower pain scores. There were no significant differences in satisfaction scores, incidence of PONV, LOS, or block performance time between the two groups.
There was a significant difference in opioid consumption between the deep and superficial SAPB groups. Subjects in the deep SAPB group had lower pain scores at 12 h; however, the difference was not statistically significant at other time points. While both the superficial and the deep SAPB can be used for post-operative analgesia in patients undergoing mastectomy, our study suggests that the deep SAPB may improve analgesia to a greater degree than the superficial SAPB as shown through decreased opioid consumption of 30% over a 24-h period post-block. CLINICAL TRIAL NUMBER AND REGISTRY URL: clinicaltrials.gov: NCT03154658.
在前锯肌平面阻滞(SAPB)的初步描述中,浅层和深层 SAPB 均可提供有效的阻滞。本研究旨在探讨乳腺切除术患者接受浅层和深层 SAPB 时阿片类药物消耗和术后镇痛的差异。
随机前瞻性试验。
学术医院。
64 名年龄>18 岁、ASA I-III 级、行单侧或双侧乳房切除术、伴或不伴淋巴结活检、伴或不伴组织扩张器重建的女性。
超声引导技术下进行浅层或深层 SAPB 联合多模式镇痛。
主要结果是 24 小时内阿片类药物的消耗量。次要结果是疼痛评分、满意度评分、PONV 发生率、住院时间和阻滞起效时间。
接受深层 SAPB 的受试者口服吗啡等效物(OME)的需求量减少 30%(113.5mg 比 147mg,p=0.009),且疼痛评分较低。两组在满意度评分、PONV 发生率、住院时间或阻滞起效时间方面均无显著差异。
深层 SAPB 组和浅层 SAPB 组的阿片类药物消耗存在显著差异。深层 SAPB 组的受试者在 12 小时时疼痛评分较低;然而,在其他时间点,差异无统计学意义。虽然浅层和深层 SAPB 均可用于乳腺切除术患者的术后镇痛,但我们的研究表明,深层 SAPB 可能在一定程度上比浅层 SAPB 更能改善镇痛,表现在 24 小时内阿片类药物消耗减少 30%。临床试验编号和注册网址:clinicaltrials.gov:NCT03154658。